Volume 29, Number 11—November 2023
Research
Duration of Enterovirus D68 RNA Shedding in the Upper Respiratory Tract and Transmission among Household Contacts, Colorado, USA
Table 3
Intervention |
All participants, N = 25 |
EV-D68–positive primary participants, n = 9 |
EV-D68–positive household contacts, n = 5 |
EV-D68–negative household contacts, n = 11 |
---|---|---|---|---|
Medications | ||||
Albuterol | 13 (52.0) | 9 (100) | 3 (60.0) | 1 (9.1) |
Antipyretic | 17 (68.0) | 9 (100) | 3 (60.0) | 5 (45.5) |
Steroids |
8 (32.0) |
7 (77.8) |
1 (20.0) |
0 |
No. outpatient visits during study period† | ||||
0 | 13 (52.0) | 1 (11.1) | 2 (40.0) | 10 (90.9) |
1 | 11 (44.0) | 7 (77.8) | 3 (60.0) | 1 (9.1) |
2 |
1 (4.0) |
1 (11.1) |
0 |
0 |
Hospital course | ||||
Required admission | 11 (44.0) | 9 (100) | 2 (40.0) | 0 |
Required ICU stay | 8 (32.0) | 8 (88.9) | 0 | 0 |
Median length of stay (IQR), d | 4.0 (3.0–6.5) | 5.0 (4.0–7.0) | 2.0 (1.5–2.5) | NA |
Median ICU length of stay (IQR), d |
2.5 (1.8–4.3) |
2.5 (1.8–4.3) |
NA |
NA |
Oxygen support at any time during admission | ||||
Supplemental oxygen | 11 (44.0) | 9 (100) | 2 (40.0) | 0 |
Noninvasive positive pressure ventilation | 7 (28.0) | 7 (77.8) | 0 | 0 |
Intubation | 1 (4.0) | 1 (11.1) | 0 | 0 |
*Values are no. (%) except as indicated. ICU, intensive care unit; IQR, interquartile range; NA, not applicable. †Includes clinic, urgent care, and emergency department visits.
Page created: October 02, 2023
Page updated: October 23, 2023
Page reviewed: October 23, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.